Phase 3 trial of Covaxin to begin in Haryana on Nov 20, Anil Vij offers to be first volunteer

Bharat Biotech had on Monday said the Phase 3 trial of Covaxin will involve 26,000 volunteers across 25 centres in India and is being conducted in partnership with the ICMR. It is the largest clinical trial conducted for a COVID-19 vaccine in India.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/3fbDRLi
via IFTTT